Evocalcet

依伏卡塞

Report date: 2025/11/21 16:08:15
NME

Base Information

Drug NameEvocalcet
Drug Alias Name伊万卡塞evocalcetumevocalcetOrkedia盖优平 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsHyperparathyroidism, SecondaryHyperparathyroidism, PrimaryHyperparathyroidism +[4] 
Global Approved IndicationsHyperparathyroidism, Secondary
Approved Indications in ChinaHyperparathyroidism, Secondary
Original Approved Country/TerritoryJapan
Original Approved Date2018/03/23
Country/TerritoryTaiwanSouth KoreaHong Kong +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin Co LtdKyowa Hakko Kirin Co LtdKyowa Hakko Kirin Co Ltd Ube Plant +[4] 
Inactive CompaniesKyowa Kirin Co Ltd Ube Plant
Active IndicationsHyperparathyroidism, Secondary
Inactive IndicationsHyperparathyroidism, PrimaryHyperparathyroidismParathyroid Neoplasms

Other Information

ATC CodeH03
Related LinksN/A